You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for New Drug Application (NDA): 008316

✉ Email this page to a colleague

« Back to Dashboard

NDA 008316 describes PRIMAQUINE, which is a drug marketed by Sanofi Aventis Us, Alvogen, Bayshore Pharms Llc, and Novast Labs, and is included in four NDAs. It is available from one supplier. Additional details are available on the PRIMAQUINE profile page.

The generic ingredient in PRIMAQUINE is primaquine phosphate. There are four drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the primaquine phosphate profile page.

Summary for 008316

Tradename:	PRIMAQUINE
Applicant:	Sanofi Aventis Us
Ingredient:	primaquine phosphate
Patents:	0

Pharmacology for NDA: 008316

Medical Subject Heading (MeSH) Categories for 008316

Antimalarials

Suppliers and Packaging for NDA: 008316

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
PRIMAQUINE	primaquine phosphate	TABLET;ORAL	008316	NDA	Sanofi-Aventis U.S. LLC	0024-1596	0024-1596-01	100 TABLET, FILM COATED in 1 BOTTLE (0024-1596-01)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	EQ 15MG BASE
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AB	RLD:	Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.